These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22022277)

  • 21. Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma.
    Hamano K; Esumi M; Igarashi H; Chino K; Mochida J; ISHIDA And H; Okada K
    J Urol; 2002 Feb; 167(2 Pt 1):713-7. PubMed ID: 11792959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma.
    Damjanovic SS; Ilic BB; Beleslin Cokic BB; Antic JA; Bankovic JZ; Milicevic IT; Rodic GS; Ilic DS; Todorovic VN; Puskas N; Tulic CD
    Exp Mol Pathol; 2016 Dec; 101(3):323-331. PubMed ID: 27845047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
    Beroukhim R; Brunet JP; Di Napoli A; Mertz KD; Seeley A; Pires MM; Linhart D; Worrell RA; Moch H; Rubin MA; Sellers WR; Meyerson M; Linehan WM; Kaelin WG; Signoretti S
    Cancer Res; 2009 Jun; 69(11):4674-81. PubMed ID: 19470766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two Single Nucleotide Polymorphisms in the Von Hippel-Lindau Tumor Suppressor Gene in Patients with Clear Cell Renal Cell Carcinoma.
    Chrabańska M; Szweda-Gandor N; Drozdzowska B
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.
    Guinot A; Lehmann H; Wild PJ; Frew IJ
    J Pathol; 2016 Jul; 239(3):365-73. PubMed ID: 27126173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
    Niu X; Zhang T; Liao L; Zhou L; Lindner DJ; Zhou M; Rini B; Yan Q; Yang H
    Oncogene; 2012 Feb; 31(6):776-86. PubMed ID: 21725364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
    Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
    Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Analysis Reveals the Important Role of the
    Lai YC; Wang WC
    Anticancer Res; 2021 Sep; 41(9):4295-4304. PubMed ID: 34475049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity?
    Batavia AA; Schraml P; Moch H
    Histopathology; 2019 Jan; 74(1):60-67. PubMed ID: 30565303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
    Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
    J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.
    Rohan SM; Xiao Y; Liang Y; Dudas ME; Al-Ahmadie HA; Fine SW; Gopalan A; Reuter VE; Rosenblum MK; Russo P; Tickoo SK
    Mod Pathol; 2011 Sep; 24(9):1207-20. PubMed ID: 21602815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.
    McRonald FE; Morris MR; Gentle D; Winchester L; Baban D; Ragoussis J; Clarke NW; Brown MD; Kishida T; Yao M; Latif F; Maher ER
    Mol Cancer; 2009 Jun; 8():31. PubMed ID: 19493342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma.
    Jilg CA; Neumann HP; Gläsker S; Schäfer O; Ardelt PU; Schwardt M; Schultze-Seemann W
    Urol Int; 2012; 88(1):71-8. PubMed ID: 22156657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity.
    Batavia AA; Rutishauser D; Sobottka B; Schraml P; Beerenwinkel N; Moch H
    Mod Pathol; 2023 Aug; 36(8):100194. PubMed ID: 37088333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
    Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
    Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic Significance of
    Kim HS; Kim JH; Jang HJ; Han B; Zang DY
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.
    Kim BJ; Kim JH; Kim HS; Zang DY
    Oncotarget; 2017 Feb; 8(8):13979-13985. PubMed ID: 28103578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and epigenetic alterations during renal carcinogenesis.
    Arai E; Kanai Y
    Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.